Alliance for Clinical Trials in Oncology
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 84
- Registration Number
- NCT00513747
- Locations
- πΊπΈ
Virginia K. Crosson Cancer Center at St. Jude Medical Center, Fullerton, California, United States
πΊπΈProvidence Saint Joseph Medical Center - Burbank, Burbank, California, United States
πΊπΈCamino Medical Group - Treatment Center, Mountain View, California, United States
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 46
- Registration Number
- NCT00509041
- Locations
- πΊπΈ
Memorial Hospital of South Bend, South Bend, Indiana, United States
πΊπΈCenter for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States
πΊπΈRebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Procedure: lobectomyProcedure: segmentectomy or wedge resection
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 701
- Registration Number
- NCT00499330
- Locations
- πΊπΈ
Saint Mary Corwin Medical Center, Pueblo, Colorado, United States
π¦πΊSaint Vincent's Hospital, Fitzroy, Victoria, Australia
πΊπΈAllegheny General Hospital, Pittsburgh, Pennsylvania, United States
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificNeurotoxicityPainPeripheral Neuropathy
- Interventions
- Other: placebo
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 231
- Registration Number
- NCT00489411
- Locations
- πΊπΈ
Sutter Health - Western Division Cancer Research Group, San Rafael, California, United States
πΊπΈEl Camino Hospital Cancer Center, Mountain View, California, United States
πΊπΈHope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: denileukin diftitoxBiological: rituximab
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 24
- Registration Number
- NCT00460109
- Locations
- πΊπΈ
Rush-Copley Cancer Care Center, Aurora, Illinois, United States
πΊπΈBoulder Community Hospital, Boulder, Colorado, United States
πΊπΈMayo Clinic Scottsdale, Scottsdale, Arizona, United States
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 110
- Registration Number
- NCT00454194
- Locations
- πΊπΈ
Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States
πΊπΈBoulder Community Hospital, Boulder, Colorado, United States
πΊπΈPenrose Cancer Center at Penrose Hospital, Colorado Springs, Colorado, United States
Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Registration Number
- NCT00450515
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
- Conditions
- Recurrent Small Intestine CancerSmall Intestine Adenocarcinoma
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 33
- Registration Number
- NCT00433550
- Locations
- πΊπΈ
Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States
πΊπΈRegions Hospital Cancer Care Center, Saint Paul, Minnesota, United States
πΊπΈToledo Hospital, Toledo, Ohio, United States
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 788
- Registration Number
- NCT00430183
- Locations
- πΊπΈ
Michiana Hematology-Oncology, PC - Elkhart, Elkhart, Indiana, United States
πΊπΈMunson Medical Center, Traverse City, Michigan, United States
πΊπΈMercy and Unity Cancer Center at Mercy Hospital, Coon Rapids, Minnesota, United States
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 36
- Registration Number
- NCT00423917
- Locations
- πΊπΈ
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States
πΊπΈNorthwest Ohio Oncology Center, Maumee, Ohio, United States
πΊπΈMount Carmel Health - West Hospital, Columbus, Ohio, United States